Recurrence of primary sclerosing cholangitis after liver transplantation-The Hungarian experience

Fanni Gelley, Gergely Zádori, Dénes Görög, L. Kóbori, Imre Fehérvári, György Gámán, Zsuzsanna Gerlei, P. Nagy, E. Sárváry, B. Nemes

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Recurrence of primary sclerosing cholangitis (rPSC) after liver transplantation (OLT) signifi cantly aff ects longterm graft survival. We aimed to evaluate the incidence of rPSC and clinical data of these patients in Hungary. Patients and Methods: We retrospectively analyzed data of 511 whole liver transplantations from 1995 to 2011. During the study period, 49 OLTs were performed in 43 adult patients with end-stage PSC (10%). Results: Out of 49 OLT, 24 cases were excluded, rPSC was diagnosed in six patients (12%). Patients with rPSC had signifi cantly higher mortality (p = 0.009) and graft loss (p = 0.009) in comparison to patients without recurrent disease. Younger recipient age, higher donor BMI was observed in the rPSC group. One patient was diagnosed with de novo IBD, the remaining fi ve patients had worsening IBD activity in the posttransplant period. PreOLT colectomy was performed in 21% of the control and none of the rPSC group. PostOLT colectomy was performed in two rPSC patients due to severe therapy resistant colitis. Conclusions: Recurrent PSC signifi cantly aff ects long-term mortality and graft loss. Younger age at OLT, higher donor BMI and severe active IBD may be associated with PSC recurrence. PreOLT total colectomy might have protective eff ect against rPSC.

Original languageEnglish
Pages (from-to)16-18
Number of pages3
JournalInterventional Medicine and Applied Science
Volume6
Issue number1
DOIs
Publication statusPublished - Mar 1 2014

Fingerprint

Sclerosing Cholangitis
Liver Transplantation
Recurrence
Colectomy
Tissue Donors
Transplants
Mortality
Hungary
Graft Survival
Colitis

Keywords

  • disease recurrence
  • inflammatory bowel disease
  • liver transplantation
  • primary sclerosing cholangitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Recurrence of primary sclerosing cholangitis after liver transplantation-The Hungarian experience. / Gelley, Fanni; Zádori, Gergely; Görög, Dénes; Kóbori, L.; Fehérvári, Imre; Gámán, György; Gerlei, Zsuzsanna; Nagy, P.; Sárváry, E.; Nemes, B.

In: Interventional Medicine and Applied Science, Vol. 6, No. 1, 01.03.2014, p. 16-18.

Research output: Contribution to journalArticle

Gelley, Fanni ; Zádori, Gergely ; Görög, Dénes ; Kóbori, L. ; Fehérvári, Imre ; Gámán, György ; Gerlei, Zsuzsanna ; Nagy, P. ; Sárváry, E. ; Nemes, B. / Recurrence of primary sclerosing cholangitis after liver transplantation-The Hungarian experience. In: Interventional Medicine and Applied Science. 2014 ; Vol. 6, No. 1. pp. 16-18.
@article{3df8cb94d6134f50a258fb26005d87cc,
title = "Recurrence of primary sclerosing cholangitis after liver transplantation-The Hungarian experience",
abstract = "Introduction: Recurrence of primary sclerosing cholangitis (rPSC) after liver transplantation (OLT) signifi cantly aff ects longterm graft survival. We aimed to evaluate the incidence of rPSC and clinical data of these patients in Hungary. Patients and Methods: We retrospectively analyzed data of 511 whole liver transplantations from 1995 to 2011. During the study period, 49 OLTs were performed in 43 adult patients with end-stage PSC (10{\%}). Results: Out of 49 OLT, 24 cases were excluded, rPSC was diagnosed in six patients (12{\%}). Patients with rPSC had signifi cantly higher mortality (p = 0.009) and graft loss (p = 0.009) in comparison to patients without recurrent disease. Younger recipient age, higher donor BMI was observed in the rPSC group. One patient was diagnosed with de novo IBD, the remaining fi ve patients had worsening IBD activity in the posttransplant period. PreOLT colectomy was performed in 21{\%} of the control and none of the rPSC group. PostOLT colectomy was performed in two rPSC patients due to severe therapy resistant colitis. Conclusions: Recurrent PSC signifi cantly aff ects long-term mortality and graft loss. Younger age at OLT, higher donor BMI and severe active IBD may be associated with PSC recurrence. PreOLT total colectomy might have protective eff ect against rPSC.",
keywords = "disease recurrence, inflammatory bowel disease, liver transplantation, primary sclerosing cholangitis",
author = "Fanni Gelley and Gergely Z{\'a}dori and D{\'e}nes G{\"o}r{\"o}g and L. K{\'o}bori and Imre Feh{\'e}rv{\'a}ri and Gy{\"o}rgy G{\'a}m{\'a}n and Zsuzsanna Gerlei and P. Nagy and E. S{\'a}rv{\'a}ry and B. Nemes",
year = "2014",
month = "3",
day = "1",
doi = "10.1556/IMAS.6.2014.1.2",
language = "English",
volume = "6",
pages = "16--18",
journal = "Interventional Medicine and Applied Science",
issn = "2061-1617",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - Recurrence of primary sclerosing cholangitis after liver transplantation-The Hungarian experience

AU - Gelley, Fanni

AU - Zádori, Gergely

AU - Görög, Dénes

AU - Kóbori, L.

AU - Fehérvári, Imre

AU - Gámán, György

AU - Gerlei, Zsuzsanna

AU - Nagy, P.

AU - Sárváry, E.

AU - Nemes, B.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Introduction: Recurrence of primary sclerosing cholangitis (rPSC) after liver transplantation (OLT) signifi cantly aff ects longterm graft survival. We aimed to evaluate the incidence of rPSC and clinical data of these patients in Hungary. Patients and Methods: We retrospectively analyzed data of 511 whole liver transplantations from 1995 to 2011. During the study period, 49 OLTs were performed in 43 adult patients with end-stage PSC (10%). Results: Out of 49 OLT, 24 cases were excluded, rPSC was diagnosed in six patients (12%). Patients with rPSC had signifi cantly higher mortality (p = 0.009) and graft loss (p = 0.009) in comparison to patients without recurrent disease. Younger recipient age, higher donor BMI was observed in the rPSC group. One patient was diagnosed with de novo IBD, the remaining fi ve patients had worsening IBD activity in the posttransplant period. PreOLT colectomy was performed in 21% of the control and none of the rPSC group. PostOLT colectomy was performed in two rPSC patients due to severe therapy resistant colitis. Conclusions: Recurrent PSC signifi cantly aff ects long-term mortality and graft loss. Younger age at OLT, higher donor BMI and severe active IBD may be associated with PSC recurrence. PreOLT total colectomy might have protective eff ect against rPSC.

AB - Introduction: Recurrence of primary sclerosing cholangitis (rPSC) after liver transplantation (OLT) signifi cantly aff ects longterm graft survival. We aimed to evaluate the incidence of rPSC and clinical data of these patients in Hungary. Patients and Methods: We retrospectively analyzed data of 511 whole liver transplantations from 1995 to 2011. During the study period, 49 OLTs were performed in 43 adult patients with end-stage PSC (10%). Results: Out of 49 OLT, 24 cases were excluded, rPSC was diagnosed in six patients (12%). Patients with rPSC had signifi cantly higher mortality (p = 0.009) and graft loss (p = 0.009) in comparison to patients without recurrent disease. Younger recipient age, higher donor BMI was observed in the rPSC group. One patient was diagnosed with de novo IBD, the remaining fi ve patients had worsening IBD activity in the posttransplant period. PreOLT colectomy was performed in 21% of the control and none of the rPSC group. PostOLT colectomy was performed in two rPSC patients due to severe therapy resistant colitis. Conclusions: Recurrent PSC signifi cantly aff ects long-term mortality and graft loss. Younger age at OLT, higher donor BMI and severe active IBD may be associated with PSC recurrence. PreOLT total colectomy might have protective eff ect against rPSC.

KW - disease recurrence

KW - inflammatory bowel disease

KW - liver transplantation

KW - primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=84896353503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896353503&partnerID=8YFLogxK

U2 - 10.1556/IMAS.6.2014.1.2

DO - 10.1556/IMAS.6.2014.1.2

M3 - Article

VL - 6

SP - 16

EP - 18

JO - Interventional Medicine and Applied Science

JF - Interventional Medicine and Applied Science

SN - 2061-1617

IS - 1

ER -